State-of-the-Art Review: Demyelinating Diseases in Indonesia
Demyelinating diseases are more common in Indonesia than previously believed. However, it is still a challenge for a country such as Indonesia to implement the scientific medical advances, especially in the diagnostic process of demyelinating diseases, to achieve the best possible outcome for these...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Multiple Sclerosis International |
Online Access: | http://dx.doi.org/10.1155/2021/1278503 |
id |
doaj-8df19e6402674a8ba1e171f373e1f48f |
---|---|
record_format |
Article |
spelling |
doaj-8df19e6402674a8ba1e171f373e1f48f2021-07-19T01:05:00ZengHindawi LimitedMultiple Sclerosis International2090-26622021-01-01202110.1155/2021/1278503State-of-the-Art Review: Demyelinating Diseases in IndonesiaHana Larassati0Riwanti Estiasari1Reyhan E. Yunus2Paul M. Parizel3Radiology DepartmentFaculty of Medicine Universitas IndonesiaRadiology DepartmentDavid Hartley Chair of RadiologyDemyelinating diseases are more common in Indonesia than previously believed. However, it is still a challenge for a country such as Indonesia to implement the scientific medical advances, especially in the diagnostic process of demyelinating diseases, to achieve the best possible outcome for these groups of patients, within the constraints of what is socially, technologically, economically, and logistically achievable. In this review, we address the 4 major classes of demyelinating disease: multiple sclerosis (MS), neuromyelitis optica (NMO), anti-MOG-associated encephalomyelitis (MOG-EM), and acute disseminated encephalomyelitis (ADEM), and discuss their prevalence, demographics, clinical diagnosis workup, and imaging features in the Indonesian population, as well as the challenges we face in their diagnosis and therapeutic approach. We hope that this overview will lead to a better awareness of the spectrum of demyelinating diseases of the central nervous system in Indonesia.http://dx.doi.org/10.1155/2021/1278503 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Hana Larassati Riwanti Estiasari Reyhan E. Yunus Paul M. Parizel |
spellingShingle |
Hana Larassati Riwanti Estiasari Reyhan E. Yunus Paul M. Parizel State-of-the-Art Review: Demyelinating Diseases in Indonesia Multiple Sclerosis International |
author_facet |
Hana Larassati Riwanti Estiasari Reyhan E. Yunus Paul M. Parizel |
author_sort |
Hana Larassati |
title |
State-of-the-Art Review: Demyelinating Diseases in Indonesia |
title_short |
State-of-the-Art Review: Demyelinating Diseases in Indonesia |
title_full |
State-of-the-Art Review: Demyelinating Diseases in Indonesia |
title_fullStr |
State-of-the-Art Review: Demyelinating Diseases in Indonesia |
title_full_unstemmed |
State-of-the-Art Review: Demyelinating Diseases in Indonesia |
title_sort |
state-of-the-art review: demyelinating diseases in indonesia |
publisher |
Hindawi Limited |
series |
Multiple Sclerosis International |
issn |
2090-2662 |
publishDate |
2021-01-01 |
description |
Demyelinating diseases are more common in Indonesia than previously believed. However, it is still a challenge for a country such as Indonesia to implement the scientific medical advances, especially in the diagnostic process of demyelinating diseases, to achieve the best possible outcome for these groups of patients, within the constraints of what is socially, technologically, economically, and logistically achievable. In this review, we address the 4 major classes of demyelinating disease: multiple sclerosis (MS), neuromyelitis optica (NMO), anti-MOG-associated encephalomyelitis (MOG-EM), and acute disseminated encephalomyelitis (ADEM), and discuss their prevalence, demographics, clinical diagnosis workup, and imaging features in the Indonesian population, as well as the challenges we face in their diagnosis and therapeutic approach. We hope that this overview will lead to a better awareness of the spectrum of demyelinating diseases of the central nervous system in Indonesia. |
url |
http://dx.doi.org/10.1155/2021/1278503 |
work_keys_str_mv |
AT hanalarassati stateoftheartreviewdemyelinatingdiseasesinindonesia AT riwantiestiasari stateoftheartreviewdemyelinatingdiseasesinindonesia AT reyhaneyunus stateoftheartreviewdemyelinatingdiseasesinindonesia AT paulmparizel stateoftheartreviewdemyelinatingdiseasesinindonesia |
_version_ |
1721295454191222784 |